secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K/A
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0000950170-23-034489
Event type: other_material
Sentiment:  positive
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MindMed 2023 annual meeting: company slate elected, FCM nominees defeated
-------------------------------------------------------------------------

- Final voting results certified July 25, 2023; unchanged from preliminary results of June 27.
- All six company board nominees elected (e.g., Robert Barrow 8.15M for vs 6.26M withheld).
- All four FCM MM Holdings nominees failed; each had more withheld votes (e.g., Dr. Scott Freeman 6.02M for, 7.78M withheld).
- KPMG LLP reappointed as auditor (14.86M for, 0.39M against, 1.08M abstain).
- Quorum 42.3% of 38.59M outstanding shares; meeting held June 21.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023034489/0000950170-23-034489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023034489/mnmd-20230621.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-034489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer